Background: Epigenetic dysregulation through ethanol (EtOH)-induced changes in DNA methylation and histone modifications has been implicated in several alcohol-related disorders such as alcoholic liver disease. EtOH metabolism in the liver results in the formation of acetate, a metabolite that can be converted to acetyl-CoA, which can then be used by histone acetyltransferases to acetylate lysine residues. EtOH metabolism in the liver can also indirectly influence lysine acetylation through NAD
Background: Epigenetic dysregulation through ethanol (EtOH)-induced changes in DNA methylation and histone modifications has been implicated in several alcohol-related disorders such as alcoholic liver disease. EtOH metabolism in the liver results in the formation of acetate, a metabolite that can be converted to acetyl-CoA, which can then be used by histone acetyltransferases to acetylate lysine residues. EtOH metabolism in the liver can also indirectly influence lysine acetylation through NAD + -dependent sirtuin activity that is altered due to increases in NADH. As a proof-of-concept study to determine the direct influence of hepatic EtOH metabolism on histone acetylation changes, we used heavy-labeled EtOH ( 13 C 2 ) and mass spectrometry (MS) to site specifically characterize lysine acetylation on histone proteins.
Methods: Eight-week-old male C57BL/6J mice were gavaged using a bolus dose of either 13 C 2 -labeled EtOH (5 g/kg) or maltose dextrin. Blood and livers were collected at 0, 4, and 24 hours followed by histone protein enrichment and derivatization using acid extraction and propionylation, respectively. Metabolic tracing and relative quantitation of acetylated histone proteins were performed using a hybrid quadrupole-orbitrap mass spectrometer. Data were analyzed using MaxQuant, Xcalibur Qual Browser, and the Bioconductor package "mzR." The contribution of EtOH to histone acetylation was quantified using the change in relative abundance of stable isotope incorporation in acetylated peptides detected by MS.
Results: Data show significant incorporation of the EtOH-derived 13 C 2 -label into N-terminal lysine acetylation sites on histones H3 and H4 after 4 hours, with rapid turnover of labeled histone acetylation sites and return to endogenous levels at 24 hours postgavage. Moreover, site-specific selectivity was observed in regard to label incorporation into certain lysine acetylation sites as determined by tandem mass spectrometry and comparison to isotope simulations.
Conclusions: These data provide the first quantitative evidence of how hepatic EtOH metabolism directly influences histone lysine acetylation in a site-specific manner and may influence EtOH-induced gene expression through these transcriptionally activating chromatin marks.
Key Words: Metabolic Tracing, Histone Acetylation, Epigenetics, Alcohol Liver Disease, Hepatocytes. C HRONIC LIVER DISEASE is consistently among the top 15 leading causes of death in the United States of which approximately 50% of those deaths are due to alcoholic liver disease (ALD) (WHO, 2014) . In terms of global impact on human health, ALD, as well as other alcoholrelated disorders, affects millions of people worldwide. Alcohol metabolism in the liver disrupts normal cellular metabolic pathways through various mechanisms including shifts in the redox potential and increases in reactive oxygen species. Interruption of redox homeostasis can ultimately lead to disruption in pathways such as lipid peroxidation, cellular signaling, inflammation, transcriptional reprogramming, and epigenetic changes, all of which can lead to liver injury (Choudhary et al., 2014; Patel et al., 2011; Turner, 1998; Verdin and Ott, 2015) . Recently, alcohol-induced epigenetic changes thought to play a role in liver injury have become of great interest; however, little is currently known about the underlying mechanisms relating to alcoholinduced epigenetic changes and liver injury.
Alcohol consumption has been demonstrated to induce changes in protein modifications such as acetylation, methylation, and phosphorylation as well as changes in DNA methylation and miRNA expression levels and function (Choudhury and Shukla, 2008; Lee and Shukla, 2007; Lieber et al., 2008; Mandrekar, 2011; Park et al., 2003; Shukla et al., 2008) . Histone modifications, in particular, are epigenetic marks that are recognized to be important for gene regulation, depending on the modification status of the N-terminal histone tail region (Choudhury et al., 2010; Ito et al., 2004; Lu and Thompson, 2012; Mandrekar, 2011; Noberini et al., 2016; Zakhari, 2013) . Histone tails regulate transcriptional processes, and alteration of their posttranslational modifications by alcohol may result in differential gene expression, impaired recruitment of transcriptional proteins, and subsequently influence biological processes throughout the cell (Choudhary et al., 2014; Patel et al., 2011; Verdin and Ott, 2015) . Understanding the underlying mechanisms of how alcohol metabolism influences epigenetic alterations of histones proteins, and furthermore, how these changes affect the progression of ALD have become increasingly important.
Recent research has shifted to understanding how ethanol (EtOH)-induced changes in lysine acetylation affect epigenetic regulation through site-specific histone modifications. Histone acetylation, in particular, is regulated by the activities of various histone acetyltransferases (HATs) and histone deacetylases (HDACs), where the activities of these enzymes are altered in hepatocytes following EtOH exposure (Choudhury and Shukla, 2008; Kim et al., 2015; Park et al., 2003 Park et al., , 2005 Park et al., , 2012 Shukla et al., 2015b) . Further studies that aimed to determine the influence of EtOH, and EtOH metabolism, on histone acetylation showed that metabolically available acetyl-CoA from acetate is vital to the increased acetylation of histone marks associated with proinflammatory genes and subsequent proinflammatory response in EtOH-treated macrophages (Kendrick et al., 2010) . Furthermore, Shukla and colleagues (2015b) reported that EtOH and acetate exhibit differential outcomes in terms of their metabolic effects on hepatic gene expression. However, the precise contribution of EtOH metabolism via acetate and subsequent acetylCoA production to histone acetylation is still unclear.
Over the past decade, new approaches in metabolic tracing using stable isotope labels and mass spectrometry (MS) have been developed to study changes in histone acetylation. Original work in this area demonstrated that 13 Clabeled glucose can be used to assess the contribution of the acetyl-CoA pool from glucose metabolism to histone acetylation utilizing quantitative MS (Evertts et al., 2013) . More recent studies show the use of 13 C-labeled glucose to study proteome-wide protein lysine acetylation following incorporation of the 13 C label into the acetyl-CoA pool (Kori et al., 2017) . Here, we build upon those experiments in the context of a novel stable isotope tracing approach using 13 C 2 -labeled EtOH in vivo. EtOH metabolism in the liver generates acetate, which contributes to the acetyl-CoA pool and, in conjunction with HATs, can be used for histone protein acetylation. Our study aims to quantitatively determine the direct influence of EtOH metabolism on hepatic histone acetylation using an in vivo binge model of alcohol exposure. This study presents a novel approach for characterizing epigenetic marks directly influenced by EtOH metabolism that can be used to facilitate our understanding of molecular mechanisms underlying ALD pathogenesis and progression.
MATERIALS AND METHODS

Mice
C57BL/6J mice (Jackson Laboratory, Sacramento, CA) were maintained at the University of South Florida animal facility, and all procedures were performed following approval by the Institutional Animal Care and Use Committee.
In Vivo Acute Bolus Gavage by Maltose-Dextran or 13 C 2 -Labeled EtOH Eight-week-old male C57BL/6J mice (n = 3/group) weighing approximately 25 g were administered an acute bolus dose of either 13 C 2 -labeled EtOH (5 g/kg) (Cat. # CLM-551-1; Cambridge Isotope, Tewksbury, MA) or an isocaloric equivalent dose of maltose dextrin (Cat. # 3653; BioServ, Flemington, NJ) as previously described by Bertola and colleagues (2013) . Blood was collected and placed in a BD Microtainer (Cat. # 365967; Franklin Lakes, NJ) followed by liver tissue collection at 0 (baseline/no gavage), 4, and 24 hours postgavage. Livers were snap-frozen in liquid nitrogen for later processing.
Blood Alcohol Concentration
Microtainers containing whole blood were allowed to clot at room temperature for 30 minutes and then spun at 10,0009g for 10 minutes using a benchtop centrifuge. Serum was collected and stored in 1.7 ll microcentrifuge tubes (Axygen, Cat. # MCT-175-A; Fisher Scientific, Hampton, NH). EtOH concentration was measured in a 96-well plate, using the Pointe Scientific diagnostic test kit (Cat. # A7504; Fisher Scientific) as per the manufacturer's instructions. Quality control was measured using the Pointe Scientific standard (Cat. # A7504-STD; Fisher Scientific) and predetermined alcohol controls (Cat. # A7504-CTL; Fisher Scientific). Samples were read at 340 nm using a Powerwave SX2 (BioTek, Winooski, VT) microplate spectrophotometer and exported to Excel (Microsoft Corp., Redmond, WA) for analysis. Serum collected from the first day was stored at À20°C and analyzed a second time with the 24-hour collections where no change was observed between analyses.
Tissue Lysis, Histone Extraction, and Peptide Derivatization Livers were thawed on ice, and 50 mg of tissue was cut and placed into 2 ml homogenization buffer containing 10 mM sodium butyrate (Alfa Aesar, Cat. # A1107922; Fisher Scientific) and protease inhibitor cocktail (Roche, Cat. # 1183617001; Sigma-Aldrich, St. Louis, MO). Tissues were broken down into a single cell suspension using a Dounce homogenizer with pestle A only. The whole cell lysate suspensions were placed into 50-ml conical tubes (Corning, Cat. # 430291, Fisher Scientific) and spun at 2009g for 10 minutes to form a pellet. The homogenization buffer was discarded, and the pellets were washed again in homogenization buffer, the spin was repeated and wash was discarded. Nuclei were isolated using a nuclear extraction buffer, which consisted of the homogenization buffer with the addition of 0.1% NP-40 (Thermo Scientific, Cat. # 28324; Fisher Scientific). Pellets were triturated 5 times using a wide-bore pipet tip and placed into microcentrifuge tubes on ice. Nuclei were centrifuged for 10 seconds, using the manual spin button in a benchtop microcentrifuge, and the supernatant containing the cytoplasmic fraction was then discarded. Nuclei were again washed in nuclear isolation buffer and centrifuged using the manual spin option and repeated once. Nuclei were then washed and spun twice in homogenization buffer to remove excess detergent before histone isolation. Histone extraction buffer was prepared by adding 0.4 N HCl (Fisher Chemical, Cat # A144-500; Fisher Scientific) to the homogenization buffer. Nuclei were resuspended in histone extraction buffer and lysed by sonication (30% amplitude, 5 seconds on/off for 1 minute) while on ice, and the supernatant was checked for complete DNA shearing by pipetting up and down. If DNA was still present after pipetting, then sonication was repeated until complete lysis and DNA shearing was achieved. Histone extract was placed at 4°C overnight, with rocking to ensure complete protein precipitation occurred. The following day, the histone extract was centrifuged at 17,0009g for 30 minutes, and the supernatant containing the histones was placed into a clean microcentrifuge tube. Histone protein was quantified using the BCA kit (Pierce, Cat. # 23225; Thermo Scientific, Hampton, New Hampshire) according to the manufacturer's instructions. Histones were placed into 5 lg aliquots and dried in a SpeedVac (Thermo Fisher Scientific, Hampton, New Hampshire) prior to chemical derivatization. Histones were derivatized by propionylation as previously described, except a 3:1 ratio of ACN (Fisher Chemical, Cat. # A998SK-4; Fisher Scientific) to propionic anhydride (SigmaAldrich, Cat. # 240311) was substituted in lieu of 2-propanol (Evertts et al., 2013) .
Liquid Chromatography-Mass Spectrometry and Data Analysis
Lypholyzed samples were resuspended with 0.1% formic acid (Fisher Chemical, Cat. # A117-50; Fisher Scientific) in HPLCgrade water (Fisher Chemical, Cat. # W5-4; Fisher Scientific). Samples were next analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) using a hybrid quadrupole-orbitrap mass spectrometer (Q Exactive Plus; Thermo Fisher Scientific). Samples were separated over a 1 hour gradient (2 to 40% acetonitrile in 0.1% formic acid) using a 50 cm 9 75 lm I.D. reversed phase column packed with 3 lm C18 material with 100 A pore size (Thermo Fisher Scientific). A precursor MS scan encompassing the range m/z 350 to 1,550 was performed at a resolution of 70,000 followed by data-dependent MS/MS acquisition of the top 10 most abundant ions performed at a resolution of 17,500. Precursor ion selection was performed using a larger isolation window (2.5 m/z) and a stepped normalized collision energy of 29 and 32 to include both light and 13 C-labeled acetylated peptides for MS/MS fragmentation as well as to induce efficient fragmentation of N-terminally propionylated peptides, respectively. Mass spectra were then processed using the MaxQuant software package (version 1.5.0.30, http://maxquant.org) employing the Andromeda search algorithm and searched against the SwissProt reference database for Mus musculus (UniProtKB, https://www.uniprot.org/, downloaded April 2017) as well as a second database of known contaminants provided by the MaxQuant suite. Parameters include a minimum peptide length of 7 amino acids, a maximum of 2 missed cleavages, and a mass tolerance of 20 ppm for the initial search. A 1.0% false discovery rate was used for both peptides and proteins with a mass error of less than 4.5 ppm for the second recalibrated search. Variable modifications included in the search consisted of lysine acetylation, heavy lysine acetylation ( 13 C 2 ), lysine and N-terminal peptide propionylation, and mono-and trimethylation of lysine and arginine. Manual data analysis by extracted ion chromatogram (XIC) and relative abundance analysis was performed using the Qual Browser program within the Xcalibur software package (version 3.0; Thermo Fisher Scientific). Reconstructed ion chromatograms were generated using a 5 ppm cutoff and precision to the fifth decimal based on the monoisotopic m/z value for each histone H3 peptide (containing H3K9/14 and H3K18/23) identified by MS and verified by MS/MS. Full scan mass spectra were averaged (n ≥ 5 spectra surrounding the chromatographic peak apex), and the absolute intensities of the 12 C and 13 C 2 peaks were determined using the "Spectrum List" function in Qual Browser.
13
C 2 / 12 C ratios for histone peptides from the EtOH and maltose dextrin groups were normalized to the baseline control (0 hour/no gavage). The normalized values were represented as a fold change over baseline. Statistical analysis was performed using a Welch's t-test (unrounded df) in order to compare the normalized values for the H3K9/14 and H3K18/23 peptides from the EtOH treatment group to corresponding timematched (maltose dextrin) controls. Raw files are publicly available at Chorus, project #1485, https://chorusproject.org.
Isotopic Precursor Intensity Extraction Using R
Precursor intensity values were extracted using the Bioconductor package "mzR" (Chambers et al., 2012) and MaxQuant search results. Raw files were converted to .mzML format using Proteowizard (Chambers et al., 2012; Martens et al., 2011) . MaxQuant "Evidence.txt" search results were used to identify modified histone H4 peptide-spectrum-matches (PSMs) for intensity extraction. MaxQuant results were filtered for modified histone PSMs containing values for "Raw file," "MS/MS Scan Number," and "MS/MS m/z" value. These values were compared to the scan header information for each .mzML file to obtain precursor scan numbers. Intensity values for monoisotopic m/z peaks were extracted from the corresponding precursor scan number, using m/z values within 0.01 m/z units of the "MS/MS m/z" value. The maximum intensity value within the given m/z window was used for each measurement. Intensity values for M + 1, M + 2, M + 3, and M + 4 peak were extracted using the "MS/MS m/z" value plus the mass difference of 13 C and 12 C divided by the charge state (1.003355/z * isotope peak). Incorporation of 13 C-labeled EtOH was calculated using the ratio of [M + 2] peak to [M] peak. Incorporation values were plotted using ggplot2 from the Tidyverse package (Wickham, 2009) .
RESULTS
Blood Alcohol Levels After Acute Alcohol Exposure Correlate with 13 C 2 Incorporation into Hepatic Histone Acetylation Over 24 Hours Eight-week-old male mice were separated into control or experimental groups based on comparable weight. The mice were gavaged with an acute dose of either 5 g/kg 13 C 2 -labeled EtOH or an isocaloric control of maltose dextrin. Serum blood EtOH concentration (BEC) levels averaged 305 mg/dl at 4 hours postgavage for mice administered a bolus dose of 13 C 2 -heavy-labeled EtOH (Fig. 1A) . Following 24 hours, serum BEC levels were comparable to control levels (Fig. 1A) . MS data analysis confirmed incorporation of the EtOH-derived stable isotope label into histone acetylation through increased relative abundance of the isotope peak corresponding to 13 C 2 . 13 C 2 -heavy label ([M + 2 peak]) incorporation after 4 hours was apparent when compared to the time-matched control (Fig. 1B,C) , followed by return to basal levels at 24 hours (Fig. 1D,E) . In order to assess the contribution of EtOH to N-terminal histone acetylation, 13 C 2 -labeled EtOH incorporation was determined using XIC analysis to identify acetylated peptides followed by isotope ratio calculation using averaged absolute intensities of the quantified independently in regard to the individual proteoform (doubly acetylated, singly acetylated [acetyl/propionyl], and doubly propionylated) of the identified peptides. XIC analysis was performed on 2 consecutive histone H3 peptides, the first is H3 (K9-R17) containing lysine residues H3K9 and H3K14, and the second peptide covers H3 (K18-R26) containing H3K18 and H3K23. Furthermore, chromatographic separation facilitated 13 C 2 / 12 C ratio calculation of the acetylated positional isomers containing H3K9 and H3K14 (Fig. 1F) as well as H3K18 and H3K23 (Fig. 1G) , allowing for site-specific quantitation of 13 C 2 incorporation. Chromatographic separation was confirmed by MS/MS analysis as demonstrated in Fig. 1F ,G where the abundant y8 was used to show site localization in the singly acetylated positional isomers containing H3K9/14 and H3K18/23, respectively. 
Site-Specific Quantitation of Lysine Acetylation Affected by EtOH Metabolism
Histone H3K9 and H3K14 proteoforms were analyzed and graphed to show fold change associated with 13 C 2 incorporation ( Fig. 2A) . Incorporation of the 13 C 2 label derived from EtOH metabolism was determined through comparison of the 13 C 2 / 12 C ratio (normalized to the 0 hour baseline control) of each peptide from the EtOH-treated group to the ratio of the matching peptides from the corresponding timematched control group (maltose dextrin gavage). Significant incorporation (p < 0.05, Welch's t-test) of 13 C 2 was observed 4 hours after EtOH gavage compared to time-matched gavage control for the doubly acetylated peptides containing H3K9/14 ( Fig. 2A) and H3K18/23 (Fig. 2B) as well as the singly acetylated positional isomers containing the same sites. Next, relative total acetylation change was quantified as a ratio of ratios, which is equal to the ratio of the sum of (Fig. 2C,D) . Total acetylation was normalized to the baseline control group. Upon comparison of the EtOH treatment group to the corresponding time-matched controls, no significant EtOH treatment-specific increase in total acetylation was observed for either the H3K9/14-or H3K18/23-containing peptides (Fig. 2C,D) . However, a significant increase in total acetylation was observed for both H3K9/14-and H3K18/23-containing peptides at 24 hours compared to the baseline control group, suggesting the experimental procedure (gavage) in addition to EtOH treatment may result in increases in histone H3 acetylation at these sites.
Isotope Simulation Determines Mixture of 13 C 2 Incorporation in the Doubly Acetylated Tryptic Peptides Containing H3K9/ K14 and H3K18/K23 After 4 Hours Mass spectra obtained from the doubly acetylated H3K9/ K14 and H3K18/K23 peptides were compared to isotope simulations of the naturally occurring peptide (Figs 3 and 4 , respectively). Figure 3A shows the predicted isotope simulation of the naturally occurring doubly acetylated peptide containing H3K9 (ac) /H3K14 (ac) . The simulated isotope distribution was found to be comparable, with no noticeable increases in the 13 C 2 peak when compared to the mass spectra obtained for the 4-hour maltose dextrin control mice (Fig. 3A,B) . However, the mice gavaged with heavy-labeled EtOH (Fig. 3C) show a marked increase at 4 hours in the relative abundance of 13 C 2 and 13 C 4 peaks when compared to the control spectrum (Fig. 3B) . Next, a mixture of isotopes was simulated to match the isotopic distribution of the EtOH-treated mice (Fig. 3D) . The simulation predicted a mixture of isotopes and found that approximately 41% of peptides were found to incorporate 13 C 2 at a single acetyl site, whereas 19% of peptides show incorporation at both sites, leaving 40% of the peptide unlabeled (Fig. 3C,D) . The same isotopic distribution analysis was completed for doubly acetylated peptide containing H3K18 (ac) /K23 (ac) (Fig. 4A-D) . Results were comparable for the control and the 12 C simulation, where both the 4-hour control mice and isotope simulation distributions closely resemble each other (Fig. 4A,B) . Again, the mice gavaged with heavy-labeled EtOH exhibited a marked increase in the 13 C 2 and 13 C 4 peaks (Fig. 4C ) when compared to their control-gavaged counterparts (Fig. 4B) . A mixture of label incorporation was again simulated to assess site selectivity of 13 C 2 incorporation in EtOH-treated mice (Fig. 4D) . Results show the doubly acetylated peptide, H3K18 (ac) /K23 (ac) , was represented by approximately 44% of peptides with 13 C 2 incorporation at a single acetylation site only, 23% at both acetyl sites ( 13 C 4 ), and 33% unlabeled when compared to the 4-hour EtOH-treated mice (Fig. 4C,  D) . These data suggest that after acute EtOH exposure, label incorporation could be selective at a single acetylation site before being incorporated at both sites ( Figs 3C,D and 4C,  D) .
Stable Isotope Incorporation Occurs for Histone H4 Acetylation After
C 2 -EtOH Exposure
The N-terminal region of histone H4 consists of 4 lysine residues, all of which can be acetylated or methylated (data not shown). Figure 5 illustrates all of the multiple combinations of lysine acetylation identified in our experimental samples by MaxQuant pertaining to the tryptic peptide containing H4K5/K8/K12/K16. Incorporation of the heavy label was observed in the EtOH-gavaged mice following 4 hours at each available H4 acetylation site independently, as well as in other numerous patterns of lysine acetylation (Fig. 5) . For example, we observed 13 C 2 incorporation on the doubly acetylated peptide H4K12 (ac) and H4K14 (ac) as well as numerous other proteoforms of the triple and tetra-acetylated peptide (Fig. 5) . Heavy label incorporation was observed after 4 hours in all identified H4-acetyl proteoforms, with the exception of the K5 (Ac) , K12 (Ac) , K16 (Ac) peptide, which did not show label incorporation until 24 hours (Fig. 5) . Quantitation of site-specific acetylation on peptides with multiple acetylation sites is confounded by differential incorporation and turnover rates of each acetyl site, and further confounded by the isobaric and isomeric nature of these peptides. Once multiple acetylation sites have incorporated the label at different rates, combined with acetylation turnover, in addition to the number of lysine residues on a single tryptic peptide, quantitation of acetylation is difficult to determine using precursor intensity values. In cases like histone H4, where the N-terminal tail sequence is lysine-rich, MS/MS was used to gain insight into heavy label incorporation at specific sites (Fig. 6, top) . Upon annotation, MS/MS spectra display a mass shift of +2 Da when a particular fragment ion containing an acetylated residue also contains the heavy label (Fig. 6, top) . As an example, when the y7 fragment peak is magnified, the isotope distribution of the y7 monoisotopic peak shows a significant contribution of 13 C 2 from EtOH as well as some contribution of 13 C 4 (Fig. 6, bottom) . In contrast, fragment ions (e.g., y5) that do not contain K12 but only K16 show a lower extent of modification. These data present challenges to quantifying label incorporation at 1 site given the number and proximity of lysine residues within the N-terminal tail region of histone H4, although MS/MS-based fragment ion quantitation could facilitate assessment of site-selective incorporation into lysine acetylation in cases where multiple lysine residues reside on a single peptide.
DISCUSSION
Chronic EtOH exposure has been shown to induce hyperacetylation of proteins within the mitochondria and cytoplasm in the liver (Fritz et al., 2013; Harris et al., 2015; Picklo, 2008; Shepard and Tuma, 2009; Shepard et al., 2010) . Furthermore, dysregulation of lysine acetylation has been found to have numerous implications in pathophysiological processes such as oncogenesis, DNA damage, and inflammation; however, its role in ALD is still largely unexplored (Kendrick et al., 2010; Kim and Yang, 2011; Kori et al., 2017; Simpson et al., 2009; Spange et al., 2009) . Emerging evidence now demonstrates a link between alcohol use and changes to histone acetylation (Choudhury and Shukla, 2008; Mandrekar, 2011; Park et al., 2003; Shukla et al., 2015a; Starkman et al., 2012) . Currently, MS-based identification and metabolic tracing techniques of histone modifications are becoming more prevalent in the identification of epigenetic changes induced by the external environment (Aroor et al., 2012; Choudhury and Shukla, 2008; Evertts et al., 2013; Kori et al., 2017; Li et al., 2013; Lin et al., 2014; Mandrekar, 2011; Nieratschker et al., 2013; Park et al., 2005; Shukla et al., 2015a,b; Starkman et al., 2012; Zee and Garcia, 2013; Zee et al., 2010) ; however, little is quantitatively known regarding site-specific histone acetylation that occurs directly from EtOH and EtOH metabolites. This study is the first of its kind to show a MS based stable isotope tracing approach for EtOH in vivo. We show a correlation between BEC levels and 13 C 2 -label incorporation on histone proteins over the course of 24 hours ( Figs 1A and 2A ,B) after a binge dose (5 g/kg) of EtOH in mice. Lysine acetylation sites, in particular, have a relatively fast turnover, typically between 1 and 2 hours, which is faster than methylation; however, acetylation turnover is still slower than phosphorylation (Kori et al., 2017) . Our data are consistent with the faster turnover of acetylated histones where we observe a rapid decrease in stable isotope-labeled histone acetylation upon metabolic clearance of EtOH in our mouse model of acute EtOH exposure.
Histone acetylation turnover in the liver is related to the activity of HAT and HDAC enzymes, where EtOH-induced modulation of expression and/or activity of these enzymes has been reported (Choudhury and Shukla, 2008; Kim et al., 2015; Park et al., 2003 Park et al., , 2005 Park et al., , 2012 Shukla et al., 2015b) . Currently, there are 18 known HDAC proteins in humans, which are classified into 4 classes based on sequence and cofactor dependence (Shepard and Tuma, 2009) . Class III HDACs (sirtuins) target a broad array of substrates including nonhistone proteins and are NAD + dependent. Therefore, alteration of the NADH/NAD + ratio from EtOH metabolism in the liver could consequently affect their activities. Several studies have investigated the role of EtOH influence on deacetylase activity, for example, SIRT3 and SIRT1 in EtOH-induced liver injury are based on modulating the acetylation status of several nonhistone substrates (Fritz et al., 2013; Picklo, 2008; You et al., 2008) . Further research into the role of other HATs/HDACs (Class I, II, and IV) has become increasingly important in understanding transcriptional regulation in the progression of alcohol-induced liver injury (Choudhury and Shukla, 2008; Kirpich et al., 2012) . For example, using a multibinge mouse model of EtOH exposure, down-regulation of Hdac1, 7, 9, 10, and 11 mRNA levels and the up-regulation of Hdac3 in conjunction with increased histone acetylation (Kirpich et al., 2012) . HDAC3 up-regulation has been linked to the expression of carnitine palmitoyltransferase 1a (Cpt1a), a gene important in alcohol-induced steatosis whose expression is mediated by increased H3K9 acetylation (Kirpich et al., 2013) . There have also been numerous reports of alcohol, or surrogate alcohols, influencing the acetylation status of H3K9, through both alteration of HAT and HDAC activity (Choudhury and Shukla, 2008; Park et al., 2003 Park et al., , 2012 . These studies suggest that HAT/HDAC-mediated histone acetylation is influenced by both alcohol and alcohol metabolites, and can largely depend on the dose and time of alcohol exposure.
The new data presented here now propose that alcohol can be incorporated, site specifically into known N-terminal histone acetylation sites that are important in chromatin remodeling and transcriptional regulation ( Fig. 2A-D) . Furthermore, when 2 or more acetylation sites are available, incorporation of heavy label occurs as a sitespecific mixture (Figs 3 and 4) . Site-specific incorporation of EtOH through its metabolite, acetate (converted to acetyl-CoA), into histone protein acetylation could suggest a specific and transient transcriptional regulation response based on the immediate reaction to the environment (acute EtOH exposure). Our findings suggest that during times of alcohol-induced stress, acetylation of histones is site specific and could regulate a selective transcriptional response related to EtOH stimulation and liver injury. Future work will investigate chronic EtOH exposure, given this particular model results in hyperacetylation, and enable us to quantify the exact contribution of EtOH metabolism on histone acetylation with focus on identifying and characterizing the functional impact of acetylation sites that are highly affected by EtOH directly.
Recent advances in MS based posttranslational modification identification and quantitation have enhanced the understanding of epigenetic mechanisms associated with disease progression (Britton et al., 2011; Evertts et al., 2013; Li et al., 2013; Zee and Garcia, 2013) . Our study is the first to show metabolic tracing of EtOH metabolism to histone acetylation using MS-based quantitation. Interestingly, these new data demonstrate that incorporation and site specificity of acetylation are time dependent where significant labeling of histone acetylation occurred at 4 hours and returned to baseline levels at 24 hours. The degree of total acetylation does not seem to change significantly and highlights the advantage of our method to determine specific subpopulations of acetylated histones, generated by either the endogenous or EtOH-derived acetyl-CoA pools. The limitation of our approach, however, is that only global histone acetylation changes can be quantified, which restricts insight on regional influences at the gene and/or promoter level.
We also found that manual data analysis was limited when analyzing peptides such as H4K5-R17, which contain multiple acetylation sites and sequences rich in lysine residues (Figs 4 and 5) . The need for the development of computational approaches that use chromatography, MS, and MS/ MS information is apparent. Our automated approach utilizes output from database search algorithms such as MaxQuant (used in this study), where intensities of the various proteoforms can be used to compare the modified and unmodified forms (Fig. 5) . As with any computational approach, data must be validated and confirmed through manual raw data evaluation (Fig. 6) . Furthermore, histone analysis by MS is often complicated by coelution of species related to other histone proteoforms Zee et al., 2010) . Coelution of simultaneous proteoforms or partially labeled peptides makes quantitation accuracy difficult when studying overall changes in alcohol-induced lysine acetylation. However, this proof-of-concept study clearly demonstrates that EtOH-derived metabolites directly influence histone acetylation. Future work will focus on delineating the impact of EtOH in both acute and chronic EtOH exposure models on histone acetylation in the liver using a larger sample size and addressing sex as a biological variable. Moreover, additional insight is needed into how other tissues may be affected based on acetate redistribution and utilization in vivo. Further research using stable isotope labeling techniques and highresolution MS will facilitate identification of novel targets and pathways directly affected by alcohol consumption and could provide new insights into the pathogenesis of ALD and other alcohol-related disorders.
